These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
77 related articles for article (PubMed ID: 4900932)
41. Clofibric and ethacrynic acids prevent experimental pyelonephritis by Escherichia coli in mice. Balagué CE; de Ruiz CS; Rey R; de Duffard AM; Nader-Macías ME FEMS Immunol Med Microbiol; 2004 Nov; 42(3):313-9. PubMed ID: 15477045 [TBL] [Abstract][Full Text] [Related]
42. [Frequency of adherent colibacillus in a population with acute pyelonephritis and a population with acute cystitis]. Monard A; Benoit G; Jacques L; Jardin A Prog Urol; 1993; 3(4):583-9. PubMed ID: 8104638 [TBL] [Abstract][Full Text] [Related]
43. Penicillin treatment and antibody response of pigs experimentally infected with Erysipelothrix insidiosa. Azechi H; Terakado N; Ninomiya K Am J Vet Res; 1972 Oct; 33(10):1963-73. PubMed ID: 5074700 [No Abstract] [Full Text] [Related]
44. Virulence of three types of Corynebacterium renale in cows. Hiramune T; Inui S; Murase N; Yanagawa R Am J Vet Res; 1971 Feb; 32(2):237-42. PubMed ID: 5545463 [No Abstract] [Full Text] [Related]
45. [Bases for the specific chemotherapy of chronic pyelonephritis]. Mössner G; Gaca A; Thelen A; Schirmeister J; Maurer H Urologe; 1969; 8(1):2-9. PubMed ID: 4902333 [No Abstract] [Full Text] [Related]
46. EXPERIMENTAL PYELONEPHRITIS: A COMPARISON OF BLOOD-BORNE AND ASCENDING PATTERNS OF INFECTION. HEPTINSTALL RH J Pathol Bacteriol; 1965 Jan; 89():71-80. PubMed ID: 14263499 [No Abstract] [Full Text] [Related]
47. [Staphylococcal infection as a predisposing factor in experimental colipyelonephritis]. Breunung M; Breunung MM; Peschel HG Padiatr Padol; 1971 Mar; 6(1):58-74. PubMed ID: 4949645 [No Abstract] [Full Text] [Related]
48. [Histological changes in the murine kidney in experimental hematogenic pyelonephritis from E. coli strains isolated from different sources]. Bakŭrdzhiev T; Marinova R Eksp Med Morfol; 1981; 20(4):237-42. PubMed ID: 7035136 [No Abstract] [Full Text] [Related]
49. [Contribution of experimental pathology to the understanding of human pyelonephritis]. Roberts JA Rev Prat; 1993 May; 43(9):1063-8. PubMed ID: 8378712 [TBL] [Abstract][Full Text] [Related]
50. [Experimental pyelonephritis. I. Complement and antibody titer in non-obstructive enterococcal pyelonephritis]. Tunn U; Brühl P Klin Wochenschr; 1969 May; 47(9):479-82. PubMed ID: 4986539 [No Abstract] [Full Text] [Related]
51. Experimental pyelonephritis: the influence of temporary and permanent ureteric obstruction on the localization of bacteria. BRUMFITT W; HEPTINSTALL RH Br J Exp Pathol; 1958 Dec; 39(6):610-7. PubMed ID: 13607919 [No Abstract] [Full Text] [Related]
52. [Method of creating a model of primary amicrobic chronic pyelonephritis]. Pytel' IuA; Zolotarev II; Ufimtseva AG; Volkova VS; Tsomyk VG Patol Fiziol Eksp Ter; 1979; (2):49-51. PubMed ID: 450465 [No Abstract] [Full Text] [Related]